EMA Withdrawn: Dynepo (epoetin delta) — Shire Pharmaceutical Contracts Limited

View source ↗

Summary

Dynepo (epoetin delta) has been withdrawn from the market by Shire Pharmaceutical Contracts Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Failure

Drugs mentioned

• Dynepo

Snippet

Status: Withdrawn. Therapeutic area: Kidney Failure, Chronic;Anemia. MAH: Shire Pharmaceutical Contracts Limited. Decision date: 29/02/2008